Efficacy and safety of abatacept in patients with rheumatoid arthritis and no prior treatment with biologics

被引：5
作者：
Contreras, Alejandro Escudero [1 ]
Carmen Castro-Villegas, M. [1 ]
Vanesa Hernandez-Hernandez, M. [2 ]
Diaz-Gonzalez, Federico [2 ]
机构：
[1] Hosp Univ Reina Sofia, Serv Reumatol, Cardoba, Spain
[2] Hosp Univ Canarias, Serv Reumatol, Tenerife, Spain
来源：
REUMATOLOGIA CLINICA | 2011年 / 7卷 / 06期
关键词：
Rheumatoid Arthritis; Abatacept; Efficacy; Safety;
D O I：
10.1016/j.reuma.2011.06.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Abatacept (ABA) is a recombinant human fusion protein that blocks co-stimulation signals on T lymphocytes, impeding their activation. Randomized and controlled trials examining efficacy and safety have been performed with ABA combined with methotrexate (MTX), vs MTX monotherapy and vs infliximab (IFB) combined with MTX in patients with Rheumatoid Arthritis and who are naive to biologic therapy. ABA has shown to be more effective than MTX and at least as effective as IFB+MTX, in terms of activity and clinical remission, physical function and reduction in radiological progression. Safety data at 7 years have shown that the drug is comparable to MTX in monotherapy and safer than the IFB+MTX combination, although infections still constitute the main risk when using ABA. This review summarizes the safety and efficacy data of the AIM, ATTEST, Phase IIb IM101-100 and AGREE trials. (C) 2011 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码：392 / 396
页数：5
相关论文
共 16 条
[1]   The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry [J].
Carbonell, J. ;
Cobo, T. ;
Balsa, A. ;
Descalzo, M. A. ;
Carmona, L. .
RHEUMATOLOGY, 2008, 47 (07) :1088-1092
[2]   The prevalence of rheumatoid arthritis in the general population of Spain [J].
Carmona, L ;
Villaverde, V ;
Hernández-García, C ;
Ballina, J ;
Gabriel, R ;
Laffon, A .
RHEUMATOLOGY, 2002, 41 (01) :88-95
[3]  
Genant H, 2009, ANN RHEUM DIS, V68
[4]   Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept - Twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial [J].
Kremer, JM ;
Dougados, M ;
Emery, P ;
Durez, P ;
Sibilia, J ;
Shergy, W ;
Steinfeld, S ;
Tindall, E ;
Becker, JC ;
Li, T ;
Nuamah, IF ;
Aranda, R ;
Moreland, LW .
ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2263-2271
[5]  
Kremer JM, 2009, ANN RHEUM DIS, V68
[6]   Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate [J].
Kremer, Joel M. ;
Genant, Harry K. ;
Moreland, Larry W. ;
Russell, Anthony S. ;
Emery, Paul ;
Abud-Mendoza, Carlos ;
Szechinski, Jacek ;
Li, Tracy ;
Teng, Julie ;
Becker, Jean-Claude ;
Westhovens, Rene .
ARTHRITIS AND RHEUMATISM, 2008, 58 (04) :953-963
[7]   Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis - A randomized trial [J].
Kremer, Joel M. ;
Genant, Harry K. ;
Moreland, Larry W. ;
Russell, Anthony S. ;
Emery, Paul ;
Abud-Mendoza, Carlos ;
Szechinski, Jacek ;
Li, Tracy ;
Ge, Zhiyu ;
Becker, Jean-Claude ;
Westhovens, Rene .
ANNALS OF INTERNAL MEDICINE, 2006, 144 (12) :865-876
[8]   Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate [J].
Schiff, M. ;
Keiserman, M. ;
Codding, C. ;
Songcharoen, S. ;
Berman, A. ;
Nayiager, S. ;
Saldate, C. ;
Li, T. ;
Aranda, R. ;
Becker, J-C ;
Lin, C. ;
Cornet, P. L. N. ;
Dougados, M. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (08) :1096-1103
[9]   The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial [J].
Schiff, M. ;
Pritchard, C. ;
Huffstutter, J. E. ;
Rodriguez-Valverde, V. ;
Durez, P. ;
Zhou, X. ;
Li, T. ;
Bahrt, K. ;
Kelly, S. ;
Le Bars, M. ;
Genovese, M. C. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (11) :1708-1714
[10]   Abatacept treatment for rheumatoid arthritis [J].
Schiff, Michael .
RHEUMATOLOGY, 2011, 50 (03) :437-449
12